Valence-Logo
Beliebt
Anmelden
Loading data for NAUT — first visit, this takes a few seconds.

Zur Watchlist hinzufügen

Nautilus Biotechnology In...

NasdaqCM: NAUT · Echtzeitkurs · USD
0.88
-0.01 (-1.12%)
Zum Schluss: Aug 17, 2026, 8:00 PM

Nautilus Biotechnology Inc. (NAUT) Stock Price, Analysis & Data

-1.12%

Keine Daten verfügbar

Geld0.63
Marktkapitalisierung112.05 Mio
Umsatz (TTM)190K
Nettogewinn (TTM)-56.52 Mio
Beta0.87
EPS (ttm)-0.45
KGV (TTM)n/a
Forward-KGV-1.19
KBV (TTM)0.85
KUV (TTM)588.91
Earnings DateOct 27, 2026
Brief1.15
Volumen486,511
Ø Vol. (20D)848,104
Eröffnung0.88
Vortagesschluss0.89
Tagesspanne0.86 - 0.91
52-Wk Range0.62 - 4.31
Analystn/a
Kurszieln/a
Dividendenn/a
Ex-Dividenden-Datumn/a

Über NAUT

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with inte...

[Mehr lesen]
Branche Biotechnology
Sektor Healthcare
IPO Datum Aug 7, 2020
Mitarbeiter 127
Börse NasdaqCM
Tickersymbol NAUT
Website https://www.nautilus.bio
Vollständiges Unternehmensprofil

Finanzielle Entwicklung

Im Jahr 2025 betrug der Umsatz von Nautilus Biotechnology 0, ein Anstieg von undefined% im Vergleich zum Vorjahr (0). Der Gewinn lag bei -59 Mio, ein Rückgang von -16.64 %.

Finanzberichte

Gewinnüberraschung

Nautilus Biotechnology hat die Quartalszahlen am Jul 28, 2026 veröffentlicht:
  • Umsatz von $10K verfehlt die Erwartungen um $0, mit Infinity% Wachstum im Jahresvergleich.
  • EPS von -0.11 übertrifft die Erwartungen um 0.03, mit 8.33% Wachstum im Jahresvergleich.

    • Nächste Ergebnisveröffentlichung

    Nautilus Biotechnology Inc. wird voraussichtlich die Quartalszahlen veröffentlichen am Oct 27, 2026, vor Börseneröffnung.
    Analysten erwarten einen Umsatz von ... Upgrade
    news image

    vor 3 Wochen · GuruFocus.com

    Nautilus Biotechnology Inc (NAUT) Q2 2026 Earnings Call Highlights: Strategic Shifts and ...

    Nautilus Biotechnology Inc (NAUT) leverages proteoform advancements and strategic collaborations to drive future growth amid financial challenges.

    news image

    vor 3 Wochen · MarketBeat

    Nautilus Biotechnology Q2 Earnings Call Highlights

    Nautilus Biotechnology (NASDAQ:NAUT) said it is shifting a significant share of its research and development resources toward proteoform applications, citing customer interest and a delay in its Broad...

    news image

    vor 2 Monaten · Simply Wall St.

    3 Penny Stocks With Market Caps Over $100M To Watch

    The market is up 1.2% over the last week, and in the past year, it has climbed an impressive 27%, with earnings expected to grow by 17% per annum. Though the term 'penny stock' might sound like a reli...

    news image

    vor 3 Monaten · Simply Wall St.

    3 Promising Penny Stocks With Market Caps Up To $900M

    The market remained flat over the last week, yet it is up 28% over the past year with earnings expected to grow by 16% per annum in the coming years. In this context, identifying stocks that combine s...

    news image

    vor 3 Monaten · Simply Wall St.

    Nautilus Biotechnology (NASDAQ:NAUT) Is In A Good Position To Deliver On Growth Plans

    Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

    Seite 1 von 2